1959R + 1980R
Alternative Names: AV 1959R + AV 1980R; Dual vaccine; DuvaxLatest Information Update: 22 Dec 2023
Price :
$50 *
At a glance
- Originator Nuravax
- Class Alzheimer vaccines; Protein vaccines; Synthetic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Alzheimer's disease
Most Recent Events
- 22 Dec 2023 Nuravax plans to file an IND application with the US FDA for Alzheimer's disease (Prevention) in 2023 (Nuravax pipeline,December 2023)
- 01 Dec 2021 Pharmacodynamics data from a preclinical trial in Alzheimer's disease released by released by Nuravax
- 22 Nov 2021 Nuravax plans a phase I trial for Alzheimer's disease (Prevention) in USA, in 2023